Key result
Adenoviral CT-1 gene therapy extends life-span by ~18% in pmn mice while reducing motor neuron degeneration.
Why the study?
Progressive motor neuronopathy (pmn) mice suffer from motoneuronal degeneration and premature death, and existing neurotrophic factors have not prevented disease onset or progression, motivating investigation of cardiotrophin-1 (CT-1) as a potential therapeutic agent.
Answers are grounded in this paper and cite their sources.
Supports further preclinical CT-1 gene therapy testing in motor neuron models; leaves open human translation from this animal study.
Cardiotrophin-1 (CT-1), an IL-6-related cytokine, causes hypertrophy of cardiac myocytes and has pleiotropic effects on various other cell types, including motoneurons. Here, we analyzed systemic CT-1 effects in progressive motor neuronopathy (pmn) mice that suffer from progressive motoneuronal degeneration, muscle paralysis, and premature death. Administration of an adenoviral CT-1 vector to newborn pmn mice leads to sustained CT-1 expression in the injected muscles and bloodstream, prolonged survival of animals, and improved motor functions. CT-1-treated pmn mice showed a significantly reduced degeneration of facial motoneuron cytons and phrenic nerve myelinated axons. The terminal innervation of skeletal muscle, grossly disturbed in untreated pmn mice, was almost completely preserved in CT-1-treated pmn mice. The remarkable neuroprotection conferred by CT-1 might become clinically relevant if CT-1 side effects, including cardiotoxicity, could be circumvented by a more targeted delivery of this cytokine to the nervous system.
No takes yet. Share an insight, caveat, or question.
Bordet et al. (1999) studied Progressive motor neuronopathy (n=38). Adenoviral cardiotrophin-1 (AdCT-1) gene transfer vs. AdLacZ-injected pmn mice was evaluated on Mean life-span (18% increase in mean life-span, p=0.0012). Intramuscular administration of an adenoviral CT-1 vector to newborn pmn mice increased mean life-span by 18% compared to control vector and reduced motor neuron degeneration.
Synapse has enriched 10 related papers. Consider them for comparative context: